Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
15 02 2019
Historique:
received: 04 04 2018
accepted: 18 01 2019
entrez: 17 2 2019
pubmed: 17 2 2019
medline: 2 4 2019
Statut: epublish

Résumé

FXR1 is an alternatively spliced gene that encodes RNA binding proteins (FXR1P) involved in muscle development. In contrast to other tissues, cardiac and skeletal muscle express two FXR1P isoforms that incorporate an additional exon-15. We report that recessive mutations in this particular exon of FXR1 cause congenital multi-minicore myopathy in humans and mice. Additionally, we show that while Myf5-dependent depletion of all FXR1P isoforms is neonatal lethal, mice carrying mutations in exon-15 display non-lethal myopathies which vary in severity depending on the specific effect of each mutation on the protein.

Identifiants

pubmed: 30770808
doi: 10.1038/s41467-019-08548-9
pii: 10.1038/s41467-019-08548-9
pmc: PMC6377633
doi:

Substances chimiques

FXR1 protein, human 0
Fxr1h protein, mouse 0
RNA-Binding Proteins 0
Ryanodine Receptor Calcium Release Channel 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

797

Subventions

Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States

Références

Cell Death Differ. 2006 Jun;13(6):935-40
pubmed: 16557273
PLoS Genet. 2013 Mar;9(3):e1003367
pubmed: 23555284
Bone Joint Res. 2015 Jul;4(7):105-16
pubmed: 26142413
Biochem Biophys Res Commun. 2010 Mar 26;394(1):153-7
pubmed: 20193664
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
PLoS Genet. 2016 Sep 08;12(9):e1006306
pubmed: 27606879
Development. 1991 Apr;111(4):1097-107
pubmed: 1652425
J Cell Biol. 1999 Dec 27;147(7):1431-42
pubmed: 10613902
J Exp Biol. 2004 Sep;207(Pt 19):3329-38
pubmed: 15326209
Trends Biochem Sci. 1998 Jun;23(6):198-9
pubmed: 9644970
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Hum Mol Genet. 2000 Jun 12;9(10):1487-93
pubmed: 10888599
Stem Cell Reports. 2016 Sep 13;7(3):411-424
pubmed: 27594590
FASEB J. 2016 Dec;30(12):4109-4119
pubmed: 27587568
Science. 1993 Oct 22;262(5133):563-6
pubmed: 7692601
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Hum Mol Genet. 2017 Dec 1;26(23):4556-4571
pubmed: 28973407
Genome Biol. 2014;15(12):550
pubmed: 25516281
Hum Mol Genet. 1998 Dec;7(13):2121-8
pubmed: 9817930
Hum Mol Genet. 2001 Nov 15;10(24):2803-11
pubmed: 11734545
Adv Exp Med Biol. 2013;768:197-211
pubmed: 23224972
J Exp Biol. 2009 Aug;212(Pt 16):2564-70
pubmed: 19648401
Genomics. 1999 Jul 15;59(2):193-202
pubmed: 10409431
J Vis Exp. 2013 Mar 22;(73):e50074
pubmed: 23542587
Immunol Rev. 2005 Dec;208:207-27
pubmed: 16313351
Nature. 1997 Sep 11;389(6647):191-4
pubmed: 9296498
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Semin Pediatr Neurol. 2011 Dec;18(4):239-49
pubmed: 22172419
Mol Cell Biol. 1996 Jul;16(7):3825-32
pubmed: 8668200
J Vis Exp. 2013 Jun 02;(76):
pubmed: 23770643
Mol Biol Cell. 2005 Sep;16(9):4350-61
pubmed: 16000371
Hum Mol Genet. 2004 Jul 1;13(13):1291-302
pubmed: 15128702
Eur J Pharmacol. 2017 Jan 5;794:8-14
pubmed: 27845067
Eur J Hum Genet. 2016 Aug;24(9):1301-9
pubmed: 26932192
Nucleic Acids Res. 2018 Jan 9;46(1):e4
pubmed: 29059327
Int J Mol Med. 2008 Jan;21(1):49-56
pubmed: 18097615
Drug Resist Updat. 2006 Dec;9(6):288-306
pubmed: 17287142
EMBO J. 1995 Nov 1;14(21):5358-66
pubmed: 7489725
BMC Genet. 2000;1:4
pubmed: 11178106
Cell Rep. 2018 Jul 31;24(5):1176-1189
pubmed: 30067974
J Med Genet. 2008 Oct;45(10):679-85
pubmed: 18628314
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):436-48
pubmed: 27239406
Brain. 2007 Aug;130(Pt 8):2024-36
pubmed: 17483490
Dev Biol. 2013 Jul 15;379(2):195-207
pubmed: 23639729
Transl Neurodegener. 2017 Mar 13;6:6
pubmed: 28293421
J Biol Chem. 2017 Jun 30;292(26):10961-10972
pubmed: 28487373
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Bioinformatics. 2009 Sep 1;25(17):2283-5
pubmed: 19542151
Curr Neurol Neurosci Rep. 2012 Feb;12(1):42-53
pubmed: 22134788
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Trends Biochem Sci. 2008 Mar;33(3):141-50
pubmed: 18291657
J Cell Sci. 2005 Mar 1;118(Pt 5):981-92
pubmed: 15731006
Cell. 1995 Sep 8;82(5):743-52
pubmed: 7545544
Hum Mol Genet. 2002 Nov 15;11(24):3007-17
pubmed: 12417522
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Muscle Nerve. 2016 Jun;53(6):984-8
pubmed: 26802438
Cell. 1993 Jul 30;74(2):291-8
pubmed: 7688265
Nat Commun. 2017 Nov 30;8(1):1875
pubmed: 29192139
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12485-90
pubmed: 18713863
Hum Mol Genet. 2003 Dec 1;12(23):3087-96
pubmed: 14532325
J Biol Chem. 1998 May 15;273(20):12360-9
pubmed: 9575189

Auteurs

María Cristina Estañ (MC)

Instituto de Investigaciones Biomédicas "Alberto Sols", CSIC-UAM, 28029, Madrid, Spain.
CIBER de Enfermedades Raras (CIBERER), ISCIII, 28029, Madrid, Spain.

Elisa Fernández-Núñez (E)

Instituto de Investigaciones Biomédicas "Alberto Sols", CSIC-UAM, 28029, Madrid, Spain.

Maha S Zaki (MS)

Department of Clinical Genetics, Human Genetics and Genome Research Division, Centre of Excellence of Human Genetics, National Research Centre, Cairo, 12311, Egypt.

María Isabel Esteban (MI)

Departamento de Anatomía Patológica, Hospital Universitario La Paz-IdiPaz-UAM, 28046, Madrid, Spain.

Sandra Donkervoort (S)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20814, USA.

Cynthia Hawkins (C)

Division of Pathology, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, ON, M5G 1X8, Canada.

José A Caparros-Martin (JA)

Instituto de Investigaciones Biomédicas "Alberto Sols", CSIC-UAM, 28029, Madrid, Spain.
CIBER de Enfermedades Raras (CIBERER), ISCIII, 28029, Madrid, Spain.
School of Pharmacy and Biomedical Sciences and Curtin Health Innovation Research Institute (CHIRI), Curtin University, Perth, WA, 6102, Australia.

Dimah Saade (D)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20814, USA.

Ying Hu (Y)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20814, USA.

Véronique Bolduc (V)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20814, USA.

Katherine Ru-Yui Chao (KR)

Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Boston, MA, 02115, USA.

Julián Nevado (J)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz-IdiPaz-UAM, 28046, Madrid, Spain.

Ana Lamuedra (A)

Bone and Joint Research Unit, The Institution of Health Research (IIS)-Fundación Jiménez Díaz, UAM, 28040, Madrid, Spain.

Raquel Largo (R)

Bone and Joint Research Unit, The Institution of Health Research (IIS)-Fundación Jiménez Díaz, UAM, 28040, Madrid, Spain.

Gabriel Herrero-Beaumont (G)

Bone and Joint Research Unit, The Institution of Health Research (IIS)-Fundación Jiménez Díaz, UAM, 28040, Madrid, Spain.

Javier Regadera (J)

Departamento de Anatomía, Histología y Neurociencia, Facultad de Medicina, Universidad Autónoma de Madrid, 28029, Madrid, Spain.

Concepción Hernandez-Chico (C)

CIBER de Enfermedades Raras (CIBERER), ISCIII, 28029, Madrid, Spain.
Servicio de Genética, Hospital Ramón y Cajal, 28034, Madrid, Spain.

Eduardo F Tizzano (EF)

CIBER de Enfermedades Raras (CIBERER), ISCIII, 28029, Madrid, Spain.
Department of Clinical and Molecular Genetics and Rare Diseases Unit, Hospital Vall d'Hebron, 08035, Barcelona, Spain.

Victor Martinez-Glez (V)

CIBER de Enfermedades Raras (CIBERER), ISCIII, 28029, Madrid, Spain.
Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz-IdiPaz-UAM, 28046, Madrid, Spain.

Jaime J Carvajal (JJ)

Centro Andaluz de Biología del Desarrollo (CSIC-UPO-JA), Universidad Pablo de Olavide, 41013, Sevilla, Spain.

Ruiting Zong (R)

Department of Molecular and Human Genetics, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine, 1250 Moursund Street, Houston, TX, 77030, USA.

David L Nelson (DL)

Department of Molecular and Human Genetics, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine, 1250 Moursund Street, Houston, TX, 77030, USA.

Ghada A Otaify (GA)

Department of Clinical Genetics, Human Genetics and Genome Research Division, Centre of Excellence of Human Genetics, National Research Centre, Cairo, 12311, Egypt.

Samia Temtamy (S)

Department of Clinical Genetics, Human Genetics and Genome Research Division, Centre of Excellence of Human Genetics, National Research Centre, Cairo, 12311, Egypt.

Mona Aglan (M)

Department of Clinical Genetics, Human Genetics and Genome Research Division, Centre of Excellence of Human Genetics, National Research Centre, Cairo, 12311, Egypt.

Mahmoud Issa (M)

Department of Clinical Genetics, Human Genetics and Genome Research Division, Centre of Excellence of Human Genetics, National Research Centre, Cairo, 12311, Egypt.

Carsten G Bönnemann (CG)

Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20814, USA.

Pablo Lapunzina (P)

CIBER de Enfermedades Raras (CIBERER), ISCIII, 28029, Madrid, Spain.
Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz-IdiPaz-UAM, 28046, Madrid, Spain.

Grace Yoon (G)

Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. grace.yoon@utoronto.ca.
Division of Neurology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, M5G 1X8, Canada. grace.yoon@utoronto.ca.

Victor L Ruiz-Perez (VL)

Instituto de Investigaciones Biomédicas "Alberto Sols", CSIC-UAM, 28029, Madrid, Spain. vlruiz@iib.uam.es.
CIBER de Enfermedades Raras (CIBERER), ISCIII, 28029, Madrid, Spain. vlruiz@iib.uam.es.
Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz-IdiPaz-UAM, 28046, Madrid, Spain. vlruiz@iib.uam.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH